CRT 2026
Endovascular
Mohammad M. Ansari, MD
Assistant Professor/ Cath Lab Director
Texas Tech University Health Sciences Center
Lubbock, Texas, United States
Disclosure information not submitted.
Robert M. Bersin, MD, MPH, FSCAI
Medical Director, Endovascular Services
Swedish Heart and Vascular (Emeritus)
Parc de la Baie Orientale, France
Disclosure(s): Nectero, Inc.: Stock-privately held company (Ongoing)
Jihad A. Mustapha, MD FACC FSCAI
Interventional Cardiologist
Lorven Heart & Vascular Institute
Ada , Michigan, United States
Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing); Cagent Vascular: Stock Options [in privately held companies] (Ongoing); Cardioflow: board member/chief medical officer, equity ownership (Ongoing), Stock-privately held company (Ongoing); Euphrates: Stock Options [in privately held companies] (Ongoing); Glift: Stock Options [in privately held companies] (Ongoing); Iatri: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Immertec: Stock Options [in privately held companies] (Ongoing); Levee Medical: Stock Options [in privately held companies] (Ongoing); Micromedical Solutions: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Reflow Medical: Grant/Research Support (Ongoing), scientific advisory board (Ongoing), Stock-privately held company (Ongoing); SoundBite Medical: Stock-privately held company (Ongoing); Transit Medical: Stock Options [in privately held companies] (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)